NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis

Abstract Never in mitosis gene A (NIMA)-related kinase 2 (NEK2), a member of the serine-threonine kinase family, is critically involved in the regulation of the cell cycle. Upregulation of NEK2 is associated with aberrant B cell proliferation, a phenomenon potentially driven by NEK2-mediated disrupt...

Full description

Saved in:
Bibliographic Details
Main Authors: Si-Ting Wu, Tian-Xiang Zhang, Zhirui Liu, Xueting An, Xiaoshan Du, Shu Yang, Ti Wu, Guanju Di, Jingshi Song, Bin Feng, Chunyang Wang, Chao Zhang
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:https://doi.org/10.1186/s12974-025-03472-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849469926828408832
author Si-Ting Wu
Tian-Xiang Zhang
Zhirui Liu
Xueting An
Xiaoshan Du
Shu Yang
Ti Wu
Guanju Di
Jingshi Song
Bin Feng
Chunyang Wang
Chao Zhang
author_facet Si-Ting Wu
Tian-Xiang Zhang
Zhirui Liu
Xueting An
Xiaoshan Du
Shu Yang
Ti Wu
Guanju Di
Jingshi Song
Bin Feng
Chunyang Wang
Chao Zhang
author_sort Si-Ting Wu
collection DOAJ
description Abstract Never in mitosis gene A (NIMA)-related kinase 2 (NEK2), a member of the serine-threonine kinase family, is critically involved in the regulation of the cell cycle. Upregulation of NEK2 is associated with aberrant B cell proliferation, a phenomenon potentially driven by NEK2-mediated disruption of the PKM1/PKM2 equilibrium. The overexpression of NEK2 in the B cell lineage may facilitate the maturation processes of B cells. Nonetheless, the precise role of NEK2 in modulating B cell-mediated immunity in autoimmune disorders remains to be fully elucidated. In this study, we demonstrate that NEK2 was significantly upregulated in multiple sclerosis (MS) patients. Pharmacological inhibition of NEK2 resulted in a marked reduction in the expression of co-stimulatory molecules CD80 and CD86 on B cells, concomitant with a suppression of their proliferation and differentiation into antibody-secreting cells (ASCs) and class-switched memory B cells (SWM). Administration of the NEK2 inhibitor INH1 in a murine model of experimental autoimmune encephalomyelitis (EAE) led to notable improvements in neurological function, amelioration of demyelination, and a decrease in the infiltration of inflammatory cells in the central nervous system (CNS) compared to vehicle-treated EAE mice. Mass cytometry analysis revealed that NEK2 inhibition downregulated the expression of co-stimulatory molecules and diminished the proportion of Th1 cells in the CD4 + T cell population. In vitro studies further substantiated that NEK2 blockade attenuated CD4 + T cell proliferation and differentiation into Th1 cells by disrupting B-T cell interactions. Collectively, these findings underscore an immunomodulatory function for NEK2 and highlight its potential as a therapeutic target in the treatment of multiple sclerosis.
format Article
id doaj-art-2903da4ba7b248abb4e01e74369bc96f
institution Kabale University
issn 1742-2094
language English
publishDate 2025-06-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj-art-2903da4ba7b248abb4e01e74369bc96f2025-08-20T03:25:19ZengBMCJournal of Neuroinflammation1742-20942025-06-0122111410.1186/s12974-025-03472-wNEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitisSi-Ting Wu0Tian-Xiang Zhang1Zhirui Liu2Xueting An3Xiaoshan Du4Shu Yang5Ti Wu6Guanju Di7Jingshi Song8Bin Feng9Chunyang Wang10Chao Zhang11Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General HospitalDepartment of Neurology, Tianjin Neurological Institute, Tianjin Medical University General HospitalDepartment of Neurology, Tianjin Neurological Institute, Tianjin Medical University General HospitalDepartment of Neurology, Tianjin Neurological Institute, Tianjin Medical University General HospitalDepartment of Neurology, Tianjin Neurological Institute, Tianjin Medical University General HospitalDepartment of Neurology, Tianjin Neurological Institute, Tianjin Medical University General HospitalDepartment of Neurology, Tianjin Neurological Institute, Tianjin Medical University General HospitalDepartment of Neurology, Tianjin Neurological Institute, Tianjin Medical University General HospitalDepartment of Neurology, Tianjin Neurological Institute, Tianjin Medical University General HospitalDepartment of Neurology, Tianjin Neurological Institute, Tianjin Medical University General HospitalDepartment of Scientific Research, Tianjin Medical University General HospitalDepartment of Neurology, Tianjin Neurological Institute, Tianjin Medical University General HospitalAbstract Never in mitosis gene A (NIMA)-related kinase 2 (NEK2), a member of the serine-threonine kinase family, is critically involved in the regulation of the cell cycle. Upregulation of NEK2 is associated with aberrant B cell proliferation, a phenomenon potentially driven by NEK2-mediated disruption of the PKM1/PKM2 equilibrium. The overexpression of NEK2 in the B cell lineage may facilitate the maturation processes of B cells. Nonetheless, the precise role of NEK2 in modulating B cell-mediated immunity in autoimmune disorders remains to be fully elucidated. In this study, we demonstrate that NEK2 was significantly upregulated in multiple sclerosis (MS) patients. Pharmacological inhibition of NEK2 resulted in a marked reduction in the expression of co-stimulatory molecules CD80 and CD86 on B cells, concomitant with a suppression of their proliferation and differentiation into antibody-secreting cells (ASCs) and class-switched memory B cells (SWM). Administration of the NEK2 inhibitor INH1 in a murine model of experimental autoimmune encephalomyelitis (EAE) led to notable improvements in neurological function, amelioration of demyelination, and a decrease in the infiltration of inflammatory cells in the central nervous system (CNS) compared to vehicle-treated EAE mice. Mass cytometry analysis revealed that NEK2 inhibition downregulated the expression of co-stimulatory molecules and diminished the proportion of Th1 cells in the CD4 + T cell population. In vitro studies further substantiated that NEK2 blockade attenuated CD4 + T cell proliferation and differentiation into Th1 cells by disrupting B-T cell interactions. Collectively, these findings underscore an immunomodulatory function for NEK2 and highlight its potential as a therapeutic target in the treatment of multiple sclerosis.https://doi.org/10.1186/s12974-025-03472-wNEK2Multiple sclerosisExperimental autoimmune encephalomyelitisB cells
spellingShingle Si-Ting Wu
Tian-Xiang Zhang
Zhirui Liu
Xueting An
Xiaoshan Du
Shu Yang
Ti Wu
Guanju Di
Jingshi Song
Bin Feng
Chunyang Wang
Chao Zhang
NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis
Journal of Neuroinflammation
NEK2
Multiple sclerosis
Experimental autoimmune encephalomyelitis
B cells
title NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis
title_full NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis
title_fullStr NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis
title_full_unstemmed NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis
title_short NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis
title_sort nek2 regulates b cell function and the severity of experimental autoimmune encephalomyelitis
topic NEK2
Multiple sclerosis
Experimental autoimmune encephalomyelitis
B cells
url https://doi.org/10.1186/s12974-025-03472-w
work_keys_str_mv AT sitingwu nek2regulatesbcellfunctionandtheseverityofexperimentalautoimmuneencephalomyelitis
AT tianxiangzhang nek2regulatesbcellfunctionandtheseverityofexperimentalautoimmuneencephalomyelitis
AT zhiruiliu nek2regulatesbcellfunctionandtheseverityofexperimentalautoimmuneencephalomyelitis
AT xuetingan nek2regulatesbcellfunctionandtheseverityofexperimentalautoimmuneencephalomyelitis
AT xiaoshandu nek2regulatesbcellfunctionandtheseverityofexperimentalautoimmuneencephalomyelitis
AT shuyang nek2regulatesbcellfunctionandtheseverityofexperimentalautoimmuneencephalomyelitis
AT tiwu nek2regulatesbcellfunctionandtheseverityofexperimentalautoimmuneencephalomyelitis
AT guanjudi nek2regulatesbcellfunctionandtheseverityofexperimentalautoimmuneencephalomyelitis
AT jingshisong nek2regulatesbcellfunctionandtheseverityofexperimentalautoimmuneencephalomyelitis
AT binfeng nek2regulatesbcellfunctionandtheseverityofexperimentalautoimmuneencephalomyelitis
AT chunyangwang nek2regulatesbcellfunctionandtheseverityofexperimentalautoimmuneencephalomyelitis
AT chaozhang nek2regulatesbcellfunctionandtheseverityofexperimentalautoimmuneencephalomyelitis